Faculty

Back to Index
Kevin Nash, PhD
Associate Professor of Clinical Pathology
Pathology
HMR 209 Health Sciences Campus Los Angeles
+1 323 442 1295

Publications

. View in: PubMed

Erratum for Brown-Elliott et al. , Utility of Sequencing the erm(41) Gene in Isolates of Mycobacterium abscessus subsp. abscessus with Low and Intermediate Clarithromycin MICs. J Clin Microbiol. 2016 Apr; 54(4):1172. View in: PubMed

Utility of Sequencing the erm(41) Gene in Isolates of Mycobacterium abscessus subsp. abscessus with Low and Intermediate Clarithromycin MICs. J Clin Microbiol. 2015 Apr; 53(4):1211-5. View in: PubMed

Absence of a Functional erm Gene in Isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum Group, Based on In Vitro Clarithromycin Susceptibility. J Clin Microbiol. 2015 Mar; 53(3):875-8. View in: PubMed

CAF-Secreted Annexin A1 Induces Prostate Cancer Cells to Gain Stem Cell-like Features. Mol Cancer Res. 2014 Apr; 12(4):607-21. View in: PubMed

Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012 Jul; 25(3):545-82. View in: PubMed

Expression of tmRNA in mycobacteria is increased by antimicrobial agents that target the ribosome. FEMS Microbiol Lett. 2011 Sep; 322(2):172-9. View in: PubMed

A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009 Apr; 53(4):1367-76. View in: PubMed

Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother. 2006 Oct; 50(10):3476-8. View in: PubMed

Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible. Antimicrob Agents Chemother. 2006 Jul; 50(7):2560-2. View in: PubMed

Molecular characterisation of Haemophilus influenzae type a and untypeable strains isolated simultaneously from cerebrospinal fluid and blood: novel use of quantitative real-time PCR based on the cap copy number to determine virulence. Clin Microbiol Infect. 2005 Aug; 11(8):637-43. View in: PubMed

Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother. 2005 Feb; 55(2):170-7. View in: PubMed

Differential virulence of Mycobacterium avium strains isolated from HIV-infected patients with disseminated M. avium complex disease. J Infect Dis. 2004 Oct 1; 190(7):1347-54. View in: PubMed

Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38). Antimicrob Agents Chemother. 2003 Oct; 47(10):3053-60. View in: PubMed

Inducible macrolide resistance in Corynebacterium jeikeium. Antimicrob Agents Chemother. 2001 Jul; 45(7):1982-9. View in: PubMed

Effect of drug concentration on emergence of macrolide resistance in Mycobacterium avium. Antimicrob Agents Chemother. 2001 Jun; 45(6):1607-14. View in: PubMed

Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay. J Infect Dis. 1997 Aug; 176(2):533-6. View in: PubMed

Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. J Infect Dis. 1996 Dec; 174(6):1218-22. View in: PubMed

Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. Antimicrob Agents Chemother. 1996 Jul; 40(7):1748-50. View in: PubMed

Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother. 1995 Dec; 39(12):2625-30. View in: PubMed

Internal controls as performance monitors and quantitative standards in the detection by polymerase chain reaction of herpes simplex virus and cytomegalovirus in clinical specimens. Mol Cell Probes. 1995 Oct; 9(5):347-56. View in: PubMed

Powered bySC CTSI